We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

The Immune System – News and Features

News

Inovio at ASGT 9th Annual Meeting

Inovio’s presentation showcase potential for electroporation in delivering DNA vaccines.
News

ThermoGenesis and Netcord Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims

These patents relate to the collection, cryopreservation and storage of hematopoietic stem cell - containing umbilical cord blood.
News

GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research

GSK has licensed from LICR a significant number of cancer antigens expressed in a large variety of cancers.
News

Life Science Pharmaceuticals Acquires Monoclonal Antibody Programs from LICR

Company plans to exploit the targeting attributes of certain product candidates by attaching tumor-fighting payloads to the antibodies.
News

Moffitt and Inovio Announce Positive Results from Human Study of Plasmid DNA Delivery Using Electroporation

Collaborators encouraged by interim data from phase I clinical study of patients with malignant melanoma.
News

Experimental flu Vaccine Bypasses Needles by Patricia Reaney

PowderMed says it would move into bigger tests of its vaccine, which uses DNA from the flu virus to stimulate immunity.
News

NIH Names Fisher Unit, Pierce, Preferred Vendor for Multiplex Protein Profiling

Pierce will provide standardized, sensitive multiplex analysis for secreted protein expression in samples submitted by the NIH.
News

Inovio Highlights Clinical and Technology Platforms for DNA Vaccines

The technology, based on the process of electroporation, uses extremely short electrical field pulses to temporarily open cell.
News

For Stanford Scientists, RNAi Gene Therapy Takes two Steps Forward, one Step Back

If RNAi is going to be viable as a therapy for organ-wide diseases such as hepatitis B or C, it will have to stick around.
News

Invitrogen Announces Broad Kinase Screening Agreement with Locus Pharmaceuticals

Screening program will utilize Invitrogen's SelectScreen™ platform
Advertisement